These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25613780)

  • 1. Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe.
    Brown D; Canton R; Dubreuil L; Gatermann S; Giske C; MacGowan A; Martinez-Martinez L; Mouton J; Skov R; Steinbakk M; Walton C; Heuer O; Struelens MJ; Diaz Hogberg L; Kahlmeter G
    Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories.
    Matuschek E; Brown DF; Kahlmeter G
    Clin Microbiol Infect; 2014 Apr; 20(4):O255-66. PubMed ID: 24131428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2014 Garrod Lecture: EUCAST - are we heading towards international agreement?
    Kahlmeter G
    J Antimicrob Chemother; 2015 Sep; 70(9):2427-39. PubMed ID: 26089441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten years of external quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in Europe elucidate high reliability of data.
    Cole MJ; Quaye N; Jacobsson S; Day M; Fagan E; Ison C; Pitt R; Seaton S; Woodford N; Stary A; Pleininger S; Crucitti T; Hunjak B; Maikanti P; Hoffmann S; Viktorova J; Buder S; Kohl P; Tzelepi E; Siatravani E; Balla E; Hauksdóttir GS; Rose L; Stefanelli P; Carannante A; Pakarna G; Mifsud F; Cassar RZ; Linde I; Bergheim T; Steinbakk M; Mlynarczyk-Bonikowska B; Borrego MJ; Shepherd J; Pavlik P; Jeverica S; Vazquez J; Abad R; Weiss S; Spiteri G; Unemo M
    BMC Infect Dis; 2019 Mar; 19(1):281. PubMed ID: 30909883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility testing breakpoints and methods from BSAC to EUCAST.
    Brown DF; Wootton M; Howe RA
    J Antimicrob Chemother; 2016 Jan; 71(1):3-5. PubMed ID: 26377864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing.
    Kahlmeter G; Brown DF; Goldstein FW; MacGowan AP; Mouton JW; Odenholt I; Rodloff A; Soussy CJ; Steinbakk M; Soriano F; Stetsiouk O
    Clin Microbiol Infect; 2006 Jun; 12(6):501-3. PubMed ID: 16700696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of EUCAST zone diameter breakpoints against reference broth microdilution.
    Bengtsson S; Bjelkenbrant C; Kahlmeter G
    Clin Microbiol Infect; 2014 Jun; 20(6):O353-60. PubMed ID: 24118469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a national EUCAST challenge panel for antimicrobial susceptibility testing.
    Desmet S; Verhaegen J; Glupzcynski Y; Van Eldere J; Melin P; Goossens H; Piérard D; Declercq P; Lagrou K; Boel A; Cartuyvels R; Denis O; Vandewal W; Saegeman V
    Clin Microbiol Infect; 2016 Aug; 22(8):704-10. PubMed ID: 27234934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanisms.
    Giani T; Morosini MI; D'Andrea MM; García-Castillo M; Rossolini GM; Cantón R
    Clin Microbiol Infect; 2012 Nov; 18(11):E452-8. PubMed ID: 22909279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?
    Marchese A; Esposito S; Barbieri R; Bassetti M; Debbia E
    BMC Infect Dis; 2012 Aug; 12():181. PubMed ID: 22866984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia.
    van der Bij AK; van Dijk K; Muilwijk J; Thijsen SF; Notermans DW; de Greeff S; van de Sande-Bruinsma N;
    Clin Microbiol Infect; 2012 Nov; 18(11):E466-72. PubMed ID: 22925456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining antibiotic resistance-towards international harmonization.
    Kahlmeter G
    Ups J Med Sci; 2014 May; 119(2):78-86. PubMed ID: 24836050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility.
    Brown D; Macgowan A
    J Antimicrob Chemother; 2010 Feb; 65(2):183-5. PubMed ID: 19996143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility testing of Kingella kingae with broth microdilution and disk diffusion using EUCAST recommended media.
    Matuschek E; Åhman J; Kahlmeter G; Yagupsky P
    Clin Microbiol Infect; 2018 Apr; 24(4):396-401. PubMed ID: 28760709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a University teaching hospital in Nairobi, Kenya: a cross-sectional study.
    Kassim A; Omuse G; Premji Z; Revathi G
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():21. PubMed ID: 27068515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparability of antimicrobial susceptibility test results from 22 European countries and Israel: an external quality assurance exercise of the European Antimicrobial Resistance Surveillance System (EARSS) in collaboration with the United Kingdom National External Quality Assurance Scheme (UK NEQAS).
    Bronzwaer S; Buchholz U; Courvalin P; Snell J; Cornaglia G; de Neeling A; Aubry-Damon H; Degener J;
    J Antimicrob Chemother; 2002 Dec; 50(6):953-64. PubMed ID: 12461017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee.
    Ellington MJ; Ekelund O; Aarestrup FM; Canton R; Doumith M; Giske C; Grundman H; Hasman H; Holden MTG; Hopkins KL; Iredell J; Kahlmeter G; Köser CU; MacGowan A; Mevius D; Mulvey M; Naas T; Peto T; Rolain JM; Samuelsen Ø; Woodford N
    Clin Microbiol Infect; 2017 Jan; 23(1):2-22. PubMed ID: 27890457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST).
    Giske CG; Turnidge J; Cantón R; Kahlmeter G;
    J Clin Microbiol; 2022 Mar; 60(3):e0027621. PubMed ID: 34346716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.
    Kahlmeter G
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():169-74. PubMed ID: 18154542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reporting antimicrobial susceptibilities and resistance phenotypes in Acinetobacter spp: a nationwide proficiency study.
    Fernández-Cuenca F; Tomás M; Caballero-Moyano FJ; Bou G; Pascual Á;
    J Antimicrob Chemother; 2018 Mar; 73(3):692-697. PubMed ID: 29244131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.